Current as of March 08, 2022 | Updated by FindLaw Staff
Welcome to FindLaw's Cases & Codes, a free source of state and federal court opinions, state laws, and the United States Code. For more information about the legal concepts addressed by these cases and statutes, visit FindLaw's Learn About the Law.
A. Laetrile may be distributed or sold by any person within this state and no special license or prescription shall be required for the sale or distribution of this nutritional supplement.
B. The label or other device affixed to a container containing laetrile shall:
1. Clearly identify the nutritional supplement contained therein as laetrile or amygdalin and, at the option of the manufacturer, vitamin B-17.
2. Include a statement that the nutritional supplement contained therein has not been approved as a treatment or cure for cancer by the food and drug administration of the United States department of health, education and welfare.
Cite this article: FindLaw.com - Arizona Revised Statutes Title 36. Public Health and Safety § 36-2452. Distribution and sale of laetrile; labeling requirements - last updated March 08, 2022 | https://codes.findlaw.com/az/title-36-public-health-and-safety/az-rev-st-sect-36-2452/
FindLaw Codes may not reflect the most recent version of the law in your jurisdiction. Please verify the status of the code you are researching with the state legislature or via Westlaw before relying on it for your legal needs.